Merge Healthcare Incorporated appears in FDA device records as the applicant behind Merge Hemo, a hemodynamic documentation product for cardiac catheterization laboratories. The most recent supplied filing, K262171, covers Merge Hemo Model RCSV2 (v11.3) and was received on June 26, 2026, with a substantially equivalent decision dated November 5, 2026. The same applicant name and Hartland, Wisconsin address appear in earlier correspondence for K233326, which covered Merge Hemo, Model RCSV2 under the programmable diagnostic computer regulation. Product descriptions published by Merative and Merge frame Merge Hemo as an automated documentation tool for the cath lab. [1][5][3]
The applicant and its documented device
FDA records identify Merge Healthcare Incorporated as the applicant for Merge Hemo (Model RCSV2 (v11.3)) under K262171, a traditional 510(k) with a Summary, reviewed in the cardiovascular advisory committee and classified under product code DQK. The filing lists the device as a programmable diagnostic computer, Class II, regulation 21 CFR 870.1425, with a cardiovascular medical specialty description. The decision description is Substantially Equivalent, dated November 5, 2026, and the submission was received June 26, 2026. [1]
An earlier clearance letter for K233326, dated June 21, 2024, addresses Merge Healthcare Incorporated at 900 Walnut Ridge Drive, Hartland, Wisconsin, and covers Merge Hemo, Model RCSV2 under the same regulation and product code. That letter states the software met its design requirements in testing with defined hardware configurations and that no new issues of safety and effectiveness were discovered, concluding substantial equivalence to a legally marketed predicate device. [5]
What Merge Hemo is documented to do
A Merative data sheet describes Merge Hemo as an automated documentation tool for the cardiac cath lab, positioned for teams handling high procedural volumes who need to avoid manual input and management of procedural data. The publisher lists capabilities including clinical workflow support, automated data collection, inventory management and clinical reporting, along with flexibility for a smaller record station footprint. These are publisher descriptions of product function, not independently verified performance results. [3]
The Merge website describes Merge Hemo as a hemodynamic solution that automates cath lab documentation into a digital patient record. The same page states that Merge Hemo ranked Best in KLAS 2026 for cardiology hemodynamics and that this was the 14th time Merge was named a leader in that category. Those recognition statements originate with the publisher. [4]
Corporate identity and brand relationships
The Merative data sheet states that Merge imaging solutions are manufactured by Merge Healthcare Incorporated, an affiliate of Merative US, LP, at 900 Walnut Ridge Drive, Hartland, Wisconsin. This is the clearest supplied statement of the relationship between the FDA applicant and the Merative brand; the sources do not establish any broader ownership structure, parentage or corporate history beyond that affiliate description. [3]
The Hartland, Wisconsin address appears in both the K262171 record and the K233326 clearance letter as a filing and correspondence address. The sources do not state a separate corporate headquarters, so none is asserted here. [1][5]
Filing scope and a recall record
The supplied portfolio snapshot, as of November 20, 2026, contains one linked 510(k) record with a single Substantially Equivalent decision, and the record sample contains that same single entry, K262171. These counts describe the supplied filings only and are not measures of total company sales, total portfolio or safety performance. [1]
A separate FDA enforcement record lists a Class 2 device recall of Merge Hemo initiated by the firm on August 11, 2025 and posted September 4, 2025, with recall number Z-2518-2025, event ID 97429, status open and classified, and 510(k) number K233326. The supplied excerpt does not state the recall's cause, affected units or corrective action, so those details remain unknown. [8]
